Ab initio molecular orbital calculations on trimethyl phosphate (TMP) were done using 6-31G* and 6-31G** basis sets, both at RHF and MP2 levels of theory. We located three minima corresponding to C 3 , C 1 , and C s symmetries, given in order of increasing energies. At the MP2/6-31G** level, the energy difference between the C 3 and C 1 conformers was 0.56 kcal/mol, while that between the C 3 and C s was 1.43 kcal/mol. Our observations are at variance with an earlier ab initio calculation, employing smaller basis sets, STO-3G* and 4-31G*, which had reported that the C 1 conformer was the lowest in energy. Furthermore, the earlier calculation did not report the occurrence of a minimum corresponding to the C s symmetry. Vibrational frequency calculations were done at the HF and MP2 levels. The computed frequencies were found to compare well with experimental vapor phase and matrix isolation data reported earlier, leading to a definitive assignment of the infrared features of TMP.
In brane world models our universe is considered as a brane imbedded into a higher dimensional space. We discuss the behaviour of geodesics in the Randall-Sundrum background and point out that free massive particles cannot move along the brane only. The brane is repulsive, and matter will be expelled from the brane into the extra dimension. This is rather undesirable, and hence we study an alternative model with a non-compact extra dimension, but with an attractive brane embedded into the higher dimensional space. We study the linearized gravity equations and show that Newton's gravitational law is valid on the brane also in the alternative background. *
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.